全文获取类型
收费全文 | 971篇 |
免费 | 137篇 |
出版年
2022年 | 11篇 |
2021年 | 14篇 |
2018年 | 19篇 |
2017年 | 7篇 |
2016年 | 8篇 |
2015年 | 28篇 |
2014年 | 40篇 |
2013年 | 44篇 |
2012年 | 49篇 |
2011年 | 50篇 |
2010年 | 34篇 |
2009年 | 25篇 |
2008年 | 37篇 |
2007年 | 43篇 |
2006年 | 26篇 |
2005年 | 25篇 |
2004年 | 42篇 |
2003年 | 27篇 |
2002年 | 21篇 |
2001年 | 22篇 |
2000年 | 27篇 |
1999年 | 27篇 |
1998年 | 18篇 |
1997年 | 18篇 |
1996年 | 14篇 |
1995年 | 17篇 |
1994年 | 7篇 |
1993年 | 9篇 |
1992年 | 21篇 |
1991年 | 24篇 |
1990年 | 30篇 |
1989年 | 28篇 |
1988年 | 23篇 |
1987年 | 17篇 |
1986年 | 13篇 |
1985年 | 12篇 |
1984年 | 16篇 |
1983年 | 12篇 |
1982年 | 15篇 |
1981年 | 20篇 |
1980年 | 8篇 |
1979年 | 18篇 |
1978年 | 16篇 |
1977年 | 10篇 |
1976年 | 11篇 |
1974年 | 12篇 |
1973年 | 12篇 |
1972年 | 10篇 |
1971年 | 11篇 |
1970年 | 8篇 |
排序方式: 共有1108条查询结果,搜索用时 203 毫秒
991.
Guanqun Zheng John Arne Dahl Yamei Niu Peter Fedorcsak Chun-Min Huang Charles J. Li Cathrine B. Vågbø Yue Shi Wen-Ling Wang Shu-Hui Song Zhike Lu Ralph P.G. Bosmans Qing Dai Ya-Juan Hao Xin Yang Wen-Ming Zhao Wei-Min Tong Xiu-Jie Wang Chuan He 《Molecular cell》2013,49(1):18-29
- Download : Download high-res image (108KB)
- Download : Download full-size image
992.
Robert A Wise Antonio Anzueto Peter Calverley Ronald Dahl Daniel Dusser Gordon Pledger Michael Koenen-Bergmann Elizabeth Joseph Daniel Cotton Bernd Disse 《Respiratory research》2013,14(1):40
Background
Tiotropium bromide is an effective therapy for COPD patients. Comparing across programs tiotropium Respimat® Soft Mist™ inhaler was at least as efficacious as tiotropium HandiHaler®, however, concerns have been raised about tiotropium’s safety when given via Respimat®.Methods
The TIOSPIR® trial () compares the safety and efficacy of tiotropium Respimat® 5 μg once daily (marketed) and 2.5 μg once daily (investigational) with tiotropium HandiHaler® 18 μ once daily (marketed). The hypotheses to be tested are 1). that tiotropium Respimat® 5 μg once daily and Respimat® 2.5 μg once daily are non-inferior to HandiHaler® in terms of all-cause mortality, and 2). that tiotropium Respimat® 5 μg once daily is superior to HandiHaler® in terms of time to first exacerbation. A spirometry substudy evaluates the bronchodilator efficacy. The trial is a randomized, double-blind, double dummy, event-driven, parallel group study. Participants can use any background treatment for COPD except inhaled anticholinergic agents. The study encompasses a wide range of COPD patients, e.g. patients with stable cardiac diseases including arrhythmia can be included. Clinical sites are international and include both primary care as well as specialists. NCT01126437Results
To date, over 17,000 participants have been randomized from over 1200 sites in 50 countries with an anticipated treatment duration of 2–3 years.Conclusion
TIOSPIR® will provide precise estimates of the relative safety and efficacy of the Respimat® and HandiHaler® formulations of tiotropium, assess potential dose-dependence of important outcomes and provide information on the clinical epidemiology of COPD in a large international patient cohort. 相似文献993.
Birgitte F. Sode Kristine H. Allin Morten Dahl Finn Gyntelberg B?rge G. Nordestgaard 《CMAJ》2013,185(5):E229-E237
Background:ABO blood type locus has been reported to be an important genetic determinant of venous and arterial thrombosis in genome-wide association studies. We tested the hypothesis that ABO blood type alone and in combination with mutations in factor V Leiden R506Q and prothrombin G20210A is associated with the risk of venous thromboembolism and myocardial infarction in the general population.Methods:We used data from 2 Danish studies that followed members of the general public from 1977 through 2010. We obtained the genotype of 66 001 white participants for ABO blood type, factor V Leiden R506Q and prothrombin G20210A. We calculated hazard ratios (HRs) and population attributable risk. Our main outcome measures were venous thromboembolism and myocardial infarction.Results:The multivariable adjusted HR for venous thromboembolism was 1.4 (95% confidence interval [CI] 1.3–1.5) for non-O blood type (v. O blood type). For the factor V Leiden R506Q mutation, the adjusted HR was 2.2 (95% CI 2.0–2.5) for heterozygous participants and 7.0 (95%CI 4.8–10) for homozygous participants (v. participants without the mutation). For prothrombin G20210A, the adjusted HR was 1.5 (95%CI 1.2–1.9) for heterozygous participants and 11 (95% CI 2.8–44) for homozygous participants (v. participants without the mutation). When we combined ABO blood type and factor V Leiden R506Q or prothrombin G20210A genotype, there was a stepwise increase in the risk of venous thromboembolism (trend, p < 0.001). The population attributable risk of venous thromboembolism was 20% for ABO blood type, 10% for factor V Leiden R506Q and 1% for prothrombin G20210A. Multivariable adjusted HRs for myocardial infarction by genotypes did not differ from 1.0.Interpretation:ABO blood type had an additive effect on the risk of venous thromboembolism when combined with factor V Leiden R506Q and prothrombin G20210A mutations; blood type was the most important risk factor for venous thromboembolism in the general population.Genome-wide association studies have reported that ABO blood type locus is an important genetic determinant of venous and arterial thrombosis,1,2 leading to renewed interest in the association between ABO blood type and venous and arterial thrombosis. This challenges conventional thoughts on genetic screening for thrombophilia, which presently does not include ABO blood type.Individuals with an A or B blood type have an increased risk of venous thromboembolism and myocardial infarction compared with individuals with O blood type.3–6 Earlier studies concluded that ABO antigen expression determines von Willebrand factor levels;7–11 however, recent findings from genome-wide association studies suggest that ABO antigens may also exert their effect through other pathways.12–16 Both factor V Leiden R506Q and prothrombin G20210A mutations have been consistently associated with increased risk of venous thrombosis but not consistently associated with the risk of arterial thrombosis.17–19In this study, we tested the hypothesis that ABO blood type, alone and in combination with the factor V Leiden R506Q and prothrombin G20210A mutations, is associated with the risk of venous thromboembolism and myocardial infarction in the general population. 相似文献
994.
Thomas P. Warelow Muse Oke Barbara Schoepp-Cothenet Jan U. Dahl Nicole Bruselat Ganesh N. Sivalingam Silke Leimkühler Konstantinos Thalassinos Ulrike Kappler James H. Naismith Joanne M. Santini 《PloS one》2013,8(8)
The arsenite oxidase (Aio) from the facultative autotrophic Alphaproteobacterium Rhizobium sp. NT-26 is a bioenergetic enzyme involved in the oxidation of arsenite to arsenate. The enzyme from the distantly related heterotroph, Alcaligenes faecalis, which is thought to oxidise arsenite for detoxification, consists of a large α subunit (AioA) with bis-molybdopterin guanine dinucleotide at its active site and a 3Fe-4S cluster, and a small β subunit (AioB) which contains a Rieske 2Fe-2S cluster. The successful heterologous expression of the NT-26 Aio in Escherichia coli has resulted in the solution of its crystal structure. The NT-26 Aio, a heterotetramer, shares high overall similarity to the heterodimeric arsenite oxidase from A. faecalis but there are striking differences in the structure surrounding the Rieske 2Fe-2S cluster which we demonstrate explains the difference in the observed redox potentials (+225 mV vs. +130/160 mV, respectively). A combination of site-directed mutagenesis and electron paramagnetic resonance was used to explore the differences observed in the structure and redox properties of the Rieske cluster. In the NT-26 AioB the substitution of a serine (S126 in NT-26) for a threonine as in the A. faecalis AioB explains a −20 mV decrease in redox potential. The disulphide bridge in the A. faecalis AioB which is conserved in other betaproteobacterial AioB subunits and the Rieske subunit of the cytochrome bc
1 complex is absent in the NT-26 AioB subunit. The introduction of a disulphide bridge had no effect on Aio activity or protein stability but resulted in a decrease in the redox potential of the cluster. These results are in conflict with previous data on the betaproteobacterial AioB subunit and the Rieske of the bc
1 complex where removal of the disulphide bridge had no effect on the redox potential of the former but a decrease in cluster stability was observed in the latter. 相似文献
995.
Zoltán Prohászka Lea Munthe-Fog Thor Ueland Timea Gombos Arne Yndestad Zsolt F?rhécz Mikkel-Ole Skjoedt Zoltan Pozsonyi Alice Gustavsen Lívia Jánoskuti István Karádi Lars Gullestad Christen P. Dahl Erik T. Askevold George Füst P?l Aukrust Tom E. Mollnes Peter Garred 《PloS one》2013,8(4)
Background
Inflammatory mechanisms involving complement activation has been shown to take part in the pathophysiology of congestive heart failure, but the initiating mechanisms are unknown. We hypothesized that the main initiator molecules of the lectin complement pathway mannose-binding lectin (MBL), ficolin-2 and ficolin-3 were related to disease severity and outcome in chronic heart failure.Methods and Results
MBL, ficolin-2 and ficolin-3 plasma concentrations were determined in two consecutive cohorts comprising 190 patients from Hungary and 183 patients from Norway as well as controls. Disease severity and clinical parameters were determined at baseline, and all-cause mortality was registered after 5-years follow-up. In univariate analysis a low level of ficolin-3, but not that of MBL or ficolin-2, was significantly associated with advanced heart failure (New York Heart Association Class IV, p<0.001 for both cohorts) and showed inverse correlation with B- type natriuretic peptide (BNP) levels (r = −0.609, p<0.001 and r = −0.467, p<0.001, respectively). In multivariable Cox regression analysis, adjusted for age, gender and BNP, decreased plasma ficolin-3 was a significant predictor of mortality (HR 1.368, 95% CI 1.052–6.210; and HR 1.426, 95% CI 1.013–2.008, respectively). Low ficolin-3 levels were associated with increased complement activation product C3a and correspondingly decreased concentrations of complement factor C3.Conclusions
This study provides evidence for an association of low ficolin-3 levels with advanced heart failure. Concordant results from two cohorts show that low levels of ficolin-3 are associated with advanced heart failure and outcome. The decrease of ficolin-3 was associated with increased complement activation. 相似文献996.
997.
Expression of 15-lipoxygenase type-1 in human mast cells 总被引:2,自引:0,他引:2
Gulliksson M Brunnström A Johannesson M Backman L Nilsson G Harvima I Dahlén B Kumlin M Claesson HE 《Biochimica et biophysica acta》2007,1771(9):1156-1165
Mast cells play a key role in the pathophysiology of asthma. These cells exert their effector functions by releasing a variety of proinflammatory and immunoregulatory compounds. Mast cells infiltrate the bronchial epithelium and smooth muscle to a higher degree in patients with asthma compared to control subjects. 15-Lipoxygenase type-1 (15-LO-1) is a prooxidant enzyme which is expressed in asthmatic lungs leading to formation of pro- and anti-inflammatory mediators. Here we report that interleukin-4 (IL-4) induced the expression of 15-LO-1 in human cord blood derived mast cells (CBMC) as demonstrated by RT-PCR, western blot and immunocytochemistry. The major metabolite of arachidonic acid formed via the 15-LO pathway in IL-4 treated CBMC was identified as 15-ketoeicosatetraenoic acid (15-KETE, also named 15-oxo-ETE) with smaller amounts of 15-hydroxyeicosatetraenoic acid (15-HETE) as identified by HPLC and mass spectrometry (MS/MS). Furthermore, immunohistochemical stainings demonstrated the expression of 15-LO-1 in mast cells in lung and skin in vivo. Osmotic activation of CBMC with mannitol resulted in activation of the 15-LO-1 pathway. In conclusion, the expression of 15-LO-1 and release of 15-LO-1 derived products by mast cells may contribute to the role of these cells in asthma and other inflammatory diseases. 相似文献
998.
Kerstin Cornils Lars Thielecke Svenja Hüser Michael Forgber Michael Thomaschewski Nadja Kleist Kais Hussein Kristoffer Riecken Tassilo Volz Sebastian Gerdes Ingmar Glauche Andreas Dahl Maura Dandri Ingo Roeder Boris Fehse 《Nucleic acids research》2014,42(7):e56
RGB marking and DNA barcoding are two cutting-edge technologies in the field of clonal cell marking. To combine the virtues of both approaches, we equipped LeGO vectors encoding red, green or blue fluorescent proteins with complex DNA barcodes carrying color-specific signatures. For these vectors, we generated highly complex plasmid libraries that were used for the production of barcoded lentiviral vector particles. In proof-of-principle experiments, we used barcoded vectors for RGB marking of cell lines and primary murine hepatocytes. We applied single-cell polymerase chain reaction to decipher barcode signatures of individual RGB-marked cells expressing defined color hues. This enabled us to prove clonal identity of cells with one and the same RGB color. Also, we made use of barcoded vectors to investigate clonal development of leukemia induced by ectopic oncogene expression in murine hematopoietic cells. In conclusion, by combining RGB marking and DNA barcoding, we have established a novel technique for the unambiguous genetic marking of individual cells in the context of normal regeneration as well as malignant outgrowth. Moreover, the introduction of color-specific signatures in barcodes will facilitate studies on the impact of different variables (e.g. vector type, transgenes, culture conditions) in the context of competitive repopulation studies. 相似文献
999.
Doroteya Raykova Joakim Klar Aysha Azhar Tahir Naeem Khan Naveed Altaf Malik Muhammad Iqbal Muhammad Tariq Shahid Mahmood Baig Niklas Dahl 《PloS one》2014,9(4)
Pure hair and nail ectodermal dysplasia (PHNED) comprises a heterogeneous group of rare heritable disorders characterized by brittle hair, hypotrichosis, onychodystrophy and micronychia. Autosomal recessive (AR) PHNED has previously been associated with mutations in either KRT85 or HOXC13 on chromosome 12p11.1-q14.3. We investigated a consanguineous Pakistani family with AR PHNED linked to the keratin gene cluster on 12p11.1 but without detectable mutations in KRT85 and HOXC13. Whole exome sequencing of affected individuals revealed homozygosity for a rare c.821T>C variant (p.Phe274Ser) in the KRT74 gene that segregates AR PHNED in the family. The transition alters the highly conserved Phe274 residue in the coil 1B domain required for long-range dimerization of keratins, suggesting that the mutation compromises the stability of intermediate filaments. Immunohistochemical (IHC) analyses confirmed a strong keratin-74 expression in the nail matrix, the nail bed and the hyponychium of mouse distal digits, as well as in normal human hair follicles. Furthermore, hair follicles and epidermis of an affected family member stained negative for Keratin-74 suggesting a loss of function mechanism mediated by the Phe274Ser substitution. Our observations show for the first time that homozygosity for a KRT74 missense variant may be associated with AR PHNED. Heterozygous KRT74 mutations have previously been associated with autosomal dominant woolly hair/hypotrichosis simplex (ADWH). Thus, our findings expand the phenotypic spectrum associated with KRT74 mutations and imply that a subtype of AR PHNED is allelic with ADWH. 相似文献
1000.
Robin Harder Yuliya Kalmykova Gregory M. Morrison Fen Feng Mikael Mangold Lisa Dahlén 《Journal of Industrial Ecology》2014,18(2):227-241
Quantifying differences in resource use and waste generation between individual households and exploring the reasons for the variations observed implies the need for disaggregated data on household activities and related physical flows. The collection of disaggregated data for water use, gas use, electricity use, and mobility has been reported in the literature and is normally achieved through sensors and computational algorithms. This study focuses on collecting disaggregated data for goods consumption and related waste generation at the level of individual households. To this end, two data collection approaches were devised and evaluated: (1) triangulating shopping receipt analysis and waste component analysis and (2) tracking goods consumption and waste generation using a smartphone. A case study on two households demonstrated that it is possible to collect quantitative data on goods consumption and related waste generation on a per unit basis for individual households. The study suggested that the type of data collected can be relevant in a number of different research contexts: eco‐feedback; user‐centered research; living‐lab research; and life cycle impacts of household consumption. The approaches presented in this study are most applicable in the context of user‐centered or living‐lab research. For the other contexts, alternative data sources (e.g., retailers and producers) may be better suited to data collection on larger samples, though at a lesser level of detail, compared with the two data collection approaches devised and evaluated in this study. 相似文献